The elderly account for the majority of medical spending in many countries, raising concerns about potentially unnecessary spending, especially during the final months of life. Using a well-defined ...
Whether a conservative strategy of medical therapy alone or a strategy of medical therapy plus invasive treatment is more beneficial in older adults with non–ST-segment elevation myocardial infarction ...
The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...
Health and Me on MSN
When every second counts: Mastering cardiovascular emergencies
Timely recognition of symptoms like chest pain, breathlessness, syncope, palpitations, or sudden neurological deficits can ...
The risk for major adverse cardiovascular events is a recognized, important complication reported among patients with ANCA-associated vasculitis.
STEMI patients without standard modifiable CV risk factors face higher 30-day mortality compared with those with at least 1 risk factor.
Myocardial infarction is an ischemic disease in which a coronary artery supplying blood to the heart muscle is stenotic or obstructed, resulting in cardiac tissue necrosis. Due to the irreversible ...
Cardiologist evaluation for post-noncardiac surgery PMI patients reduces one-year risks of major adverse cardiac events and all-cause death.
MedPage Today on MSN
Cervical Precancers Linked to Increased Heart Risks
HPV is hypothesized to affect vascular inflammation and atherosclerosis, researchers say ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results